Tess Cosad
Co-Founder/CEO

Béa Fertility provides clinical fertility treatment delivered directly to the patient's home, guided by specialists. The service utilizes an FDA-cleared insemination device as part of a simple, injection-free treatment plan that avoids clinic visits. This approach offers accessible, clinician-guided care designed to support individuals experiencing unexplained infertility or mild to moderate male factor infertility.
Raised to date
$4.8MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.





Many individuals and couples face challenges accessing traditional fertility treatments due to high costs, invasive procedures, and the stress associated with timed intercourse and clinical settings. This lack of access can delay or prevent them from starting or expanding their families.
Béa Fertility offers an at-home intracervical insemination (ICI) treatment that provides a less invasive and more accessible alternative to traditional fertility treatments like IUI and IVF. The Béa Treatment kit includes a specially designed applicator that delivers sperm directly to the cervix, increasing the chances of conception. This method eliminates the need for timed intercourse and can be performed in the comfort and privacy of one's home, reducing stress and providing greater control over the fertility journey. Béa Fertility also provides personalized guidance, expert consultations, and access to a supportive community, empowering individuals and couples throughout the process. The Béa Applicator concentrates semen at the opening of the cervix, delivering up to 3.2x more sperm into the cervical mucus than sexual intercourse.
Béa Fertility primarily targets individuals and couples who are experiencing difficulty conceiving, including those seeking a less invasive alternative to traditional fertility treatments, LGBTQIA+ couples, and those who prefer the convenience and privacy of at-home insemination.